about
The safety of influenza vaccines in children: An Institute for Vaccine Safety white paperAssociation Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and PertussisCompulsory vaccination and conscientious or philosophical exemptions: past, present, and futureGenomics and infectious disease: a call to identify the ethical, legal and social implications for public health and clinical practiceAvailability of Litigation as a Public Health Tool for Firearm Injury Prevention: Comparison of Guns, Vaccines, and Motor VehiclesReadyVax: A new mobile vaccine information app.Ethics, pandemics, and the duty to treat.Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccinesSuccess of program linking data sources to monitor H1N1 vaccine safety points to potential for even broader safety surveillance.Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program.The association between intentional delay of vaccine administration and timely childhood vaccination coverage.Factors associated with refusal of childhood vaccines among parents of school-aged children: a case-control study.Vaccine knowledge and practices of primary care providers of exempt vs. vaccinated children.Parental refusal of pertussis vaccination is associated with an increased risk of pertussis infection in children.Epidemiology of vaccine hesitancy in the United StatesNonmedical vaccine exemptions and pertussis in California, 2010.The case for a gender-neutral (universal) human papillomavirus vaccination policy in the United States: Point.Missing the Target for Routine Human Papillomavirus Vaccination: Consistent and Strong Physician Recommendations Are Lacking for 11- to 12-Year-Old MalesPhysicians' human papillomavirus vaccine recommendations, 2009 and 2011.A systematic review of interventions for reducing parental vaccine refusal and vaccine hesitancy.Nonmedical exemptions to immunization requirements in California: a 16-year longitudinal analysis of trends and associated community factors.Hurdles to herd immunity: Distrust of government and vaccine refusal in the US, 2002-2003.Religious and philosophical exemptions from vaccination requirements and lessons learned from conscientious objectors from conscriptionMeasles at Disneyland, a problem for all ages.Pertussis resurgence and vaccine uptake: implications for reducing vaccine hesitancy.Association of vaccine-related attitudes and beliefs between parents and health care providers.Did the influenza A (H1N1) 2009 monovalent inactivated vaccines increase the risk for Guillain-Barré syndrome?Immunization safety in US print media, 1995-2005.Disparities in preschool immunization coverage associated with maternal age.Editorial commentary: Guillain-Barré syndrome and vaccinations.Exemptions From Mandatory Immunization After Legally Mandated Parental Counseling.Trends in Kindergarten Rates of Vaccine Exemption and State-Level Policy, 2011-2016.Exemptions to school immunization requirements: the role of school-level requirements, policies, and procedures.Impact of addition of philosophical exemptions on childhood immunization rates.Public health and the politics of school immunization requirements.Geographic Clustering of Nonmedical Exemptions to School Immunization Requirements and Associations With Geographic Clustering of PertussisEnhancing Public Confidence in Vaccines Through Independent Oversight of Postlicensure Vaccine SafetyVaccination in Australia
P50
Q26773027-2A9E3103-4E63-4CA2-8C48-E579BF3DFC73Q28078001-3705E203-4B9B-496A-AEFE-94F538C91F6BQ28295595-AB3E2A63-2B6E-4743-BF9D-8C95A850D006Q28543022-2AD297D1-DB85-460B-B177-D0E68DFEBFFBQ28972347-01AEAE51-03CC-4081-BCFA-DA0DA46EA465Q30151483-F5BF0375-A782-40D6-9CB5-B089248FE19FQ30372132-29ADE04A-3B4C-4113-9CA0-F056F6BF9CCCQ30382146-1933A78F-250A-41B1-B698-3F199AB14A32Q30423251-9D512130-D415-4B8E-8D72-5E940FE85E58Q30428338-06544EC4-939E-4AC8-82AA-06393468F67BQ30431960-39C79193-85CA-4DFA-876D-592DA0219D16Q33876202-73817EB8-EA64-466B-9833-E8EF5DA38D71Q33901428-532ADC75-01E2-45FA-B2E7-49AAD6E94114Q33986805-C487A141-FC1A-4E73-8B8D-C6EC374F0731Q34011218-9941F5DF-FEE4-41DA-9D25-1429AE6A803DQ34017770-27066EA6-C03A-4512-91A3-74553ACD6DA2Q34170008-7C79D498-DEF4-48E6-839C-28E50869DAAEQ34374427-54F5D197-98CD-4E16-BEED-EC9417213649Q37132548-4E30FD6F-14A9-49A6-B32C-671B8FE86911Q37309897-2E38E537-E036-4146-9B12-F398727DEBC0Q37494226-C8CF2F06-5569-4505-AB1D-E22BD6A3B2CCQ38122006-D16229E8-A9DE-4CDC-B880-F6395D10431DQ40110467-6F35F519-130E-4314-A9EC-0AE58A7D3E70Q40682017-156AE4BC-8406-404D-8F61-DF99422844E4Q41178265-E95B903B-D728-4660-8CCA-6623BB9F84E0Q42156307-7CE3927B-A03A-4A73-9B72-793C0A3969FCQ42199162-4379F48F-13E2-4A41-A81F-DEED9E548977Q43433551-AE9BED6E-5321-4C4F-8CF2-804BA6AEC05BQ43700573-933D177D-8B8D-47AE-BAB8-630A1560C0AEQ44326252-51DD1B09-47AC-448D-9918-A845CA2D8861Q45054445-C6E7838C-FD39-4886-BA0F-5A166CDCD2B4Q45329074-22696712-34C0-4080-9B6F-0BA3CE7B8A8AQ47190221-7BB69A3E-6196-4430-94D4-2A95FA5958B2Q49418750-0C8FBB94-7B47-4A50-AD09-4309A3C895BEQ52973766-D88A5452-6371-41EF-AF70-F55016114A73Q53205516-23F4927E-4E31-4511-9E04-1D66FB3D131FQ54730390-6F2D4DEE-F572-4229-92BB-D2124013821FQ57954062-7BFACAF1-846F-4BC9-91A0-ADD4AAA7E608Q57954164-E1A55592-5143-4EF2-87F9-CE0157D45729Q80022054-B4F7F4A4-7609-4D27-A0C2-E412C5B1CB36
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Daniel A Salmon
@ast
Daniel A Salmon
@en
Daniel A Salmon
@es
Daniel A Salmon
@nl
type
label
Daniel A Salmon
@ast
Daniel A Salmon
@en
Daniel A Salmon
@es
Daniel A Salmon
@nl
prefLabel
Daniel A Salmon
@ast
Daniel A Salmon
@en
Daniel A Salmon
@es
Daniel A Salmon
@nl
P106
P1153
7202423181
P21
P31
P496
0000-0002-1035-4422